<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" coord="1,140.44,113.97,334.48,15.78;1,196.24,131.90,222.87,15.78">LITL at CLEF eHealth2016: recognizing entities in French biomedical documents</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName coords="1,152.04,170.89,81.07,9.96"><forename type="first">Lydia-Mai</forename><surname>Ho-Dac</surname></persName>
							<email>hodac@univ-tlse2.fr</email>
							<affiliation key="aff0">
								<orgName type="department">CLLE-ERSS</orgName>
								<orgName type="institution" key="instit1">CNRS</orgName>
								<orgName type="institution" key="instit2">University of Toulouse</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName coords="1,255.24,170.89,70.42,9.96"><forename type="first">Ludovic</forename><surname>Tanguy</surname></persName>
							<email>tanguy@univ-tlse2.fr</email>
							<affiliation key="aff0">
								<orgName type="department">CLLE-ERSS</orgName>
								<orgName type="institution" key="instit1">CNRS</orgName>
								<orgName type="institution" key="instit2">University of Toulouse</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName coords="1,347.79,170.89,63.17,9.96"><forename type="first">Céline</forename><surname>Grauby</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Master LITL</orgName>
								<orgName type="institution">University of Toulouse</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName coords="1,433.10,170.89,30.21,9.96;1,141.34,182.85,17.43,9.96"><forename type="first">Heu</forename><surname>Aurore</surname></persName>
						</author>
						<author>
							<persName coords="1,162.09,182.85,19.64,9.96"><surname>Mby</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Master LITL</orgName>
								<orgName type="institution">University of Toulouse</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName coords="1,203.87,182.85,68.64,9.96"><forename type="first">Justine</forename><surname>Malosse</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Master LITL</orgName>
								<orgName type="institution">University of Toulouse</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName coords="1,294.65,182.85,59.82,9.96"><forename type="first">Laura</forename><surname>Rivière</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Master LITL</orgName>
								<orgName type="institution">University of Toulouse</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName coords="1,376.60,182.85,97.41,9.96"><forename type="first">Amélie</forename><surname>Veltz-Mauclair</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Master LITL</orgName>
								<orgName type="institution">University of Toulouse</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName coords="1,280.82,194.80,75.86,9.96"><forename type="first">Marine</forename><surname>Wauquier</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Master LITL</orgName>
								<orgName type="institution">University of Toulouse</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" coord="1,140.44,113.97,334.48,15.78;1,196.24,131.90,222.87,15.78">LITL at CLEF eHealth2016: recognizing entities in French biomedical documents</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">188782CDB0D28AA659AC866DCDFC275E</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2024-06-26T15:45+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>This paper describes the participation of master's students (LITL programme, university of Toulouse) and their teachers to the CLEF eHealth 2016 campaign. Two runs were submitted for task 2 (multilingual information extraction) which consisted in the recognition and categorization of medical entities in French biomedical documents. The system used consists of a CRF classier based on a number of dierent features (POS tagging, generic word lists and syntactic parsing). In addition, several patterns were used on the CRF's output in order to extract more complex entities. The best run achieved high precision (0.640.78) but lower recall (0.320.40), with an overall F1-measure of 0.430.53.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">Introduction</head><p>This article describes the participation of the students of the LITL master to the CLEF eHealth 2016 Lab <ref type="bibr" coords="1,262.03,444.82,9.96,9.96" target="#b4">[5]</ref>.</p><p>LITL (stands for Linguistique, Informatique, Technologies du Langage, i.e. Linguistics, IT, Language technologies) is a new master's program at the University of Toulouse, France. Mainly aimed at linguistics and humanities students, it comprises, for a major part, courses in natural language processing (NLP), computational linguistics and practical aspects of corpus analysis through programming and using various computer tools. An important part of this curriculum is project-oriented, and the rst year students have to build a fully operational processing system for a precise NLP task. This year's project was the participation to the CLEF eHealth challenge, more precisely task 2: multilingual Information Extraction <ref type="bibr" coords="1,184.45,564.37,14.61,9.96" target="#b9">[10]</ref>.</p><p>The teachers in charge of this project (members of the CLLE-ERSS laboratory) deemed that this task was ideal for pedagogical purposes: information extraction (and more precisely named entity recognition NER) is a well-known, well-dened and central task in modern NLP; state of the art information extraction systems are based on machine learning techniques but can also make use of symbolic handcrafted rule-based approaches;</p><p>supervised learning systems such as CRF classiers can take advantage of dierent kind of linguistic resources, many of these are available for the biomedical domain; a collaborative task is an excellent exercise for students, as it motivates them and gives them a clear feedback on their work; the target language of CLEF eHEalth 2016 is French, the students' working language; the task's schedule was perfectly suited to the master's calendar.</p><p>Working as a team along the entire semester, the students were thus able (with help from their teachers) to submit two runs for the selected task, and got very satisfactory results for a rst attempt.</p><p>This paper is organized as follows. Section 2 describes the tasks and get a closer look at the data. Section 3 gives a precise description of the dierent components of the system designed for the task, while the results are given and discussed in Section 4.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">Task description 2.1 Overview</head><p>The LITL team participation only concerns the CLEF 2016 eHealth task 2 phase 1 addressing biomedical NER in French texts. The aim is to automatically detect and classify biomedical entities. Detection requires the system to provide start and end positions of each relevant entities. The classication step consists in associating each previously detected entity with one of the ten target categories corresponding to UMLS Semantic Group: Anatomy (ANAT), Chemical and Drugs (CHEM), Devices (DEVI), Disorders (DISO), Geographic Areas (GEOG), Living Beings (LIVB), Objects (OBJC), Phenomena (PHEN), Physiology (PHYS), Procedures (PROC).</p><p>Two text types are concerned with this task: drug inserts and biomedical research papers' titles and (sub)headings. Biomedical entities cover a wide range of linguistic expressions such as drug or city names, very common nouns (e.g. "inrmière" (nurse), "études" (studies)), technical specialized terms (e.g. "thyroglobuline", "électronystagmographie") or complex phrases (e.g. "infectés par le virus de l'immunodécience humaine" (infected with human immunodeciency virus), "enfant âgé de plus de trois mois" (children over 3 months)).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Data</head><p>The training data set corresponds to the QUAERO French Medical Corpus <ref type="bibr" coords="3,465.09,140.65,15.50,9.96" target="#b10">[11]</ref> previously used in CLEF 2015 eHealth task 1b <ref type="bibr" coords="3,335.63,152.60,15.50,9.96" target="#b11">[12]</ref> and made of two sub-corpora: EMEA: 6 drug inserts written by the European Medicines Agency Both sub-corpora have been manually annotated following similar guidelines <ref type="bibr" coords="3,134.77,425.77,14.61,9.96" target="#b10">[11]</ref>. Each annotation is encoded in the BRAT stando annotation format <ref type="foot" coords="3,456.84,423.67,3.97,7.94" target="#foot_2">3</ref> and includes for each entity an id, the relevant UMLS category, the oset position (start and end) and the textual content of the annotation. Example 3 gives the manual annotations associated with example 2 and Figure <ref type="figure" coords="3,388.85,461.64,4.98,9.96" target="#fig_0">1</ref>   As for the detection subtask, annotated entities can be single words (77%) or compounds (23%). Compound entities may be autonomous (e.g. "prise en charge"); nested such as in <ref type="bibr" coords="4,258.41,277.75,12.73,9.96" target="#b2">(3)</ref> where "leucocytes" is nested in "migration des leucocytes" which is in turn nested in "test de migration des leucocytes"; or discontinuous such as "hépatites C " and "virus des hépatites C " in (4 Because discontinuous entities are very rare, we decided to not detect such entities. Concerning nested entities which are more frequent, we implemented post-processing as described in Section 3.</p><p>As for classication subtask, entities are heterogeneously distributed among ten types. Half of the annotated entities are categorized as DISO (26%) or CHEM (25%). The rest spread mainly among PROC (16%), ANAT (11%) and LIVB (11%) while types PHYS, OBJC, DEVI, GEOG and PHEN are fairly rare. When compound, entities seem to be usually categorized as the rst (head) component (e.g. "virus des hépatites C " is labeled LIVB as for "virus"). Preliminary linguistic observations of data reveal three main characteristics that will constitute features for our system. First, the length of single-word annotated entities (in characters) seems longer than non-annotated words with an average of 9.5 characters against 5.5. Secondly, single-word entities show some morphological complexity with a use of recurrent productive axes such as cyte, thérapie, endocrino, trachéo. Finally, annotated entities may be mainly characterized as technical vocabulary in the biomedical domain especially for main types (DISO and CHEM).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">System description</head><p>In this section we present in details the system we designed for this task. Its cornerstone is a Conditional Random Field (CRF) classier <ref type="bibr" coords="5,401.68,262.25,10.51,9.96" target="#b5">[6]</ref> that is used to train a model based on the manually tagged datasets. Although CRFs are easily applied thanks to readily available toolkits such as CRF++ <ref type="foot" coords="5,405.37,284.06,3.97,7.94" target="#foot_3">4</ref> , they require a certain amount of preprocessing and are known to perform better when given additional information on the tokens to analyze. Also, they cannot by themselves provide all the solutions, especially when the target entities are nested and/or overlap, that's why several post-processing procedures were necessary as well.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">Overview</head><p>As is mandatory with machine learning supervised techniques, we rst had to build a model based on the training data. This was done according to the scheme presented in gure 2. As can be seen, this sequence starts with the raw text les from the training dataset, corrects their tokenization, performs POS tagging and syntactic parsing, then adds an additional set of features and nally provides, along with the annotated les, input for the CRF training phase. The result is a CRF model that can be used in the extraction phase.</p><p>The overall process used for extracting and categorizing entities from raw text les can be seen in gure 3. We can see that it applies roughly the same modules as for the training phase, but adds an additional post-processing step after the CRF classier.</p><p>The stages are described in details in the following sections.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">Preprocessing: correction, POS tagging and parsing</head><p>The rst set of modules concerns the processing of text les. The main role of these modules is to provide a generic annotation layer for the tokens: POS tagging, lemmatization and dependency parsing, as these additional information are to be used by the CRF classier.</p><p>For both phases, we used the Talismane toolkit <ref type="bibr" coords="5,367.64,623.15,15.50,9.96" target="#b12">[13]</ref> for POS tagging and dependency parsing, with the provided models for French and using the default  parameters. In addition to being a reliable tagger and dependency parser, Talismane provides the oset for each token, which is vital for dealing with the BRAT stando annotation format.</p><p>The tokenization correction module has been developed in order to prevent many tagging errors due to the non-standard blank spaces that appear in both the training and test text les. The main problems were due to additional spaces before and/or after commas, hyphens, apostrophes, periods, digits, etc. For example, an extraneous space between "l " and the following apostrophe prevented the tagger and parser from identifying a determiner. This correction module is a simple Perl script using regular expressions to convert texts back to their supposedly original punctuation, while keeping the additional spaces in order to preserve the osets for the annotated and extracted entities. For example, extract in ( <ref type="formula" coords="7,184.68,276.52,4.24,9.96">5</ref>) becomes ( <ref type="formula" coords="7,240.36,276.52,4.24,9.96">6</ref> The output of the parser follows a column-based format, in which each token is described on a separate line, as in the example <ref type="bibr" coords="7,343.24,580.37,12.73,9.96" target="#b6">(7)</ref>  As can be seen, unknown tokens (i.e. absent from the reference lexicon used by Talismane) have no corresponding lemma. We added correction procedure that reproduces the word form instead of the "_" placeholder. The POS tags indicate the token's nature (e.g. DETerminer, Verb, ADVerb, etc.) while the syntactic tag indicate its function in the sentence, more precisely the relation it has with its syntactic governor, such as object, modier, etc. Details on both tagsets can be found in the Talismane documentation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">Adding features from external resources</head><p>In addition to the lemma, POS and syntactic relations, we added several features we deemed relevant with the task (see 2). These features are the following: does the token appear in a specic word lists? what is the token's length in number of characters? does the token begin with a recognizable prex? does the token end with a recognizable sux?</p><p>These features and the way they were calculated are described in the following paragraphs</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Word lists</head><p>We used several word lists in order to extend the lexical coverage beyond what is present in the training datasets. We used two main sources: SNOMED and a list of commercial drug names.</p><p>SNOMED <ref type="bibr" coords="9,197.61,167.21,15.50,9.96" target="#b13">[14]</ref> is a well-known and used resource for biomedical NLP, as it contains extensive word lists. We selected the 4 most relevant top categories, and extracted all the single-word terms in each one.</p><p>As noted above (Section 2), manual observation of the training data (especially the EMEA subset) revealed that a large number of commercial names of drug were present and systematically tagged as CHEM entities. Given that SNOMED only contains scientic names of chemicals, we wanted to use an additional resource to tag these specic tokens, as performed by several named entities recognition systems <ref type="bibr" coords="9,257.86,263.38,10.51,9.96" target="#b7">[8]</ref> We used the Vidal website <ref type="foot" coords="9,264.14,273.76,3.97,7.94" target="#foot_4">5</ref> , which is the reference compendium for pharmaceutical drugs in France. After downloading the list of raw drug names it provides, we developed an adhoc Perl script that identies the main name through removal of extraneous information such as posology indications (i.e. transforming "ABSTRAL 100 µg cp subling" into "Abstral ").</p><p>Table <ref type="table" coords="9,177.37,336.17,4.98,9.96" target="#tab_4">2</ref> gives the number of terms used and a few examples for each of the selected 5 categories. In the end, each token is then associated with a tag (column) containing the SNOMED/VIDAL category (chem, morph, proc or phys) if its lemma appears in the corresponding word list, or none in other cases.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Token length</head><p>As noted above from an observation of the training data, word length can be a good indicator for biomedical terms. Given that the CRF classier cannot deal with numerical feature, we used a qualitative measure of the length using the following scale: short &lt; 6 ≤ medium &lt; 10 ≤ long .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Axes</head><p>Two additional features based on axes were designed in order to help technical specialized vocabulary detection. It is well known that biomedical technical terms are extensively coined through the use of standard suxes and prexes. Identifying these be a useful addition to the necessarily limited reference word lists for entity recognition <ref type="bibr" coords="10,275.55,142.24,10.51,9.96" target="#b7">[8,</ref><ref type="bibr" coords="10,287.72,142.24,7.01,9.96" target="#b8">9]</ref>. We thus compiled lists of French prexes and suxes. We relied on existing lists (most of them seemingly compiled for the training of medicine students):</p><p>Lexique des racines, préxes et suxes des termes scientiques et médicaux by D. Pol, found at http://www.didier-pol.net/ Lexique des axes (préxes et suxes) by A. Abbara, found at http:// www.aly-abbara.com/litterature/medicale/affixes/a.html Terminologie médicale : préxes et suxes by P. Cauwel, found at https:// sites.google.com/site/cauwelphilippe/Home/terminologie-medicale-prefixes-et-suffixes Once merged, these lists provided 394 prexes and 126 suxes. For each token, the longest prex (resp. sux) in the list matching its lemma was used as an additional tag, and none when no match could be found.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">From BRAT to BIO: selection of entities from the training set</head><p>Viewing the task of entity recognition and categorization as a tagging task requires the data (both training and testing) to be transformed into a compatible scheme. If the BRAT stando annotation format is perfect for the visualization and declaration of these entities, it is not appropriate for an automated tagging process.</p><p>The BIO format is traditionally used for expressing token sequences such as chunks or named entities (cf. <ref type="bibr" coords="10,263.51,404.39,10.51,9.96" target="#b2">[3,</ref><ref type="bibr" coords="10,275.69,404.39,7.75,9.96" target="#b0">1,</ref><ref type="bibr" coords="10,285.09,404.39,7.75,9.96" target="#b1">2]</ref> for NER in biomedical texts). Its principle is the following: each token in a text can be at the Beginning, Inside or Outside an entity. Because entity categorization must be performed, the B (resp. I) letter is completed by the name of the entity's category. For example, to express the fact that "Hypersensibilité retardée" is a DISO we tag "Hypersensbilité" as DISO_B and "retardée" as DISO_I.</p><p>Thus dened, the task for the CRF classier is to tag each token with one of the 21 possible value (there are 10 target entity categories, so 10 X_B and 10 X_I, but only one O). This task is thus formally similar to other NLP tagging tasks such as POS tagging, where a target value has to be decided according to the descriptive features of the token (and, in the case of CRF, to the features and values of the neighboring tokens).</p><p>An alternative scheme is known as BILOU and adds the possibility for a token to be the Last token or to be the Unique one for this entity (cf. <ref type="bibr" coords="10,453.91,559.81,10.51,9.96" target="#b3">[4]</ref> for NER in biomedical domain). Although more precise, its main disadvantage is to increase the number of possible tags (41 in our case), making it harder for the classier and generally requiring a larger amount of training data in order to be reliable (see <ref type="bibr" coords="10,189.63,607.63,10.51,9.96" target="#b6">[7]</ref> for a comparison between BIO and BILOU scores).</p><p>However, none of these schemes is able to faithfully represent nested, overlapping or discontinuous entities. As noted above, in section 2 (example 3), "Hypersensibilité retardée" contains two entities: "Hypersensibilité" and "Hypersensibilité retardée". Both are of the DISO category, and both begins with the word "Hypersensibilité". However, only one of them be represented using the BIO format. The same goes for more complex situations like the sequence "test de migration des leucocytes", still in example 3.</p><p>A decision had to be made when translating the annotated entities into the BIO format: do we keep the longest entities or the shortest? More precisely, do we consider "leucocytes" to be an ANAT entity by itself (thus receiving an ANAT_B tag) or part of the PHYS entity "migration des leucocytes" (with an PHYS_I tag)? This decision impacts the whole process, as what is decided for the training phase of the CRF will of course directly inuence what is produced in the tagging phase.</p><p>This dilemma could be summarized as a choice between fewer but more complex entities versus more small ones. We decided to choose the latter, as we deemed it easier to "rebuild" complex entities from smaller ones than the other way around.</p><p>At this stage, each text is represented by a set of features available for each token, along with a BIO tag for the training data, as is the case in example <ref type="bibr" coords="11,467.87,301.13,12.73,9.96" target="#b7">(8)</ref> derived from ( <ref type="formula" coords="11,197.07,313.09,3.87,9.96">7</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5">CRF templates and parameters</head><p>As noted above, we chose to use a CRF (CRF++) in order to predict the BIO tag for each token given the features described in the previous sections.</p><p>Training the CRF requires to dene a template, i.e. a selection of which pieces of information are given as an input to the model. The specicity of CRF systems is that they can take into account both the features associated to the target token and the ones of its neighbors. Thus, a template is used to dene which feature(s) of which neighbor(s) are used. In summary, after a number of trial runs using the training data, we opted for the following: word form of target token and of the tokens appearing in a size-2 window around it; POS tag of target token and of the tokens appearing in a size-2 window around it; length, prex, sux, and presence in word lists of the target token; BIO tag attributed to the previous token.</p><p>Moreover, the second run submitted uses the syntactic dependency tag of the target token, in addition to the previous features. This decision followed a rst experiment to evaluate the contribution of each dierent features. The system evaluation was conducted by using the original train/devel split provided for the training data. Table <ref type="table" coords="12,227.14,383.77,4.98,9.96" target="#tab_6">3</ref> gives some results of a lesion studies, i.e. indicating for each feature how their removal from the template aects the task system's performances. F-scores were calculated by using the BRATeval.jar script provided by the organizers (exact matching option on true). As table <ref type="table" coords="12,408.00,419.64,4.98,9.96" target="#tab_6">3</ref> shows, syntac- tic feature contribution depends on the syntactic characteristics of texts: when texts have uncommon syntax as for MEDLINE items (see 2), using the syntactic information may worsen results. All other features have a positive contribution to the model for both target subsets, and thus has been kept in the system. We considered separating the training subsets (EMEA and MEDLINE) and creating dierent models, but experiments in this direction were inconclusive, so we decided to use all the training data as a whole and to use the same model for both test subsets.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6">From BIO to BRAT: identifying complex named NE</head><p>The nal stage of the tagging phase is the translation from the BIO format back to the target BRAT stando annotation format. Beyond simple format conversion, the main problem here is the reconstruction of entities, assuming the choices made in the training phase and addressing the limitations of the BIO format.</p><p>This stage is performed in two steps. The rst one is a simple identication of entities, blindly following the BIO format. It means that, for each token tagged as XXX_B we extract one (and only one) entity, comprising the initial tokens along with all following tokens tagged as YYY_I. For example, we extract "hyperplasie focale modulaire" as a single DISO entity from the following output: In case of inconsistency between the categories (i.e. if XXX is dierent from YYY), we attribute the initial (XXX) category to the NEs.</p><p>As explained above, the choices made initially imply that at this stage we only get non-nested entities, although most of the time they are parts of larger entities. For example, given the following sequence in the CRF output: Example 10. tuberculose (NC) DISO_B médiastinale (ADJ) ANAT_B the rst step extracts two separate entities: "tuberculose" as a DISO and "médiastinale" as a ANAT. In order to extract some of the more complex entities, we designed a few extraction patterns, based on the POS tags. The rst pattern looks for a noun tagged as B, followed by an adjective tagged as B, i.e. the exact situation found in the example 10. Its output is the concatenation of both tokens, tagged with the category of the head noun. This means that this patterns produces "tuberculose médiastinale" as a DISO.</p><p>Similar patterns have been designed for longer sequences of adjectives: NC (B) ADJ (B) ADJ (B or I), and for nominal compounds such as NC (B) de/du/des/au/aux NC (B) and NC (B) P DET NC (B).</p><p>All extracted entities are collected in the BRAT stando annotation format as noted above. The osets are immediately available thanks to Talismane output format and the content of the entity is a simple concatenation of their tokens' word forms. <ref type="bibr" coords="13,134.77,617.15,6.72,13.45" target="#b3">4</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results and discussion</head><p>In this last section we present and discuss the results obtained by our system on the task's test data.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1">Main results</head><p>As indicated in Table <ref type="table" coords="14,229.83,141.24,3.87,9.96" target="#tab_7">4</ref>, our F1 scores are the average (of submitted runs) for entity recognition in EMEA and slightly under it for MEDLINE with, for all subsets, a high precision and a low recall. The non-exact matching scoring procedure means that the osets of the entities can partially overlap instead of being perfectly aligned. Run1 (without syntactic feature) and run2 (with A closer look at the scores per category shows that we get the highest performance on EMEA texts for LIVB entities recognition with a 0.86 F1 (0.93 P and 0.8 R, 268 entities), followed by PROC (0.7 F1, 269 entities) and CHEM (0.67 F1, 885 entities). The detection of DISO entities, which cover the largest part of biomedical entities (988 entities in MEDLINE and 342 in EMEA), is better in MEDLINE texts (0.66 F1) than in EMEA texts (0.57 F1).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.2">Test data set overview and errors observation</head><p>To better understand our system weaknesses, we propose a quick observation of the test dataset, then an overview of the false negatives (FN) and false positives (FP). First of all, an overview of test data reveals a dierence from the training data that may explain some of our FN. Indeed, as indicated in table 5, while the proportion of compounds is approximatively the same than in training data set, If we take a closer look at FP and FN, we may distinguish several cases (all subsequent examples come from the EMEA subset). First, FPs may be due to a disagreement on entity category such as the CHEM polydextrose or diacétate de glycérol which our system both classied as DISO. A comparison between run1 and the gold standard shows 187 cases of such miscategorization (60 in EMEA and 127 in MEDLINE), with quite a lot of confusions about subtle distinctions such as between OBJC physical objects and DEVI devices or between PROC procedures and CHEM chemical and drugs. As for example, in <ref type="bibr" coords="15,408.79,345.33,16.38,9.96" target="#b10">(11)</ref>, "injection" was automatically categorized PROC instead of CHEM and "seringue" (syringe) was automatically categorized OBJC instead of DEVI. The subcutaneous injection must be conducted in the same way as with a classical syringe Classication errors may also be linked with polysemy as for example with the word "bouton" which means either a concrete object (button) or an anatomic/physiological entity (pimple).</p><p>A second group of FPs may be linked to the well-known problem of distinguishing between specialized vs. common usages. Such cases occur when a common word or compound was incorrectly recognized as biomedical entities (e.g. "anomalies" recognized as DISO or "Mélange de couleur bleu" as CHEM).</p><p>A last possible explanation for FPs is related to compounds boundaries as for example when a CHEM is syntactically linked to a LIVB but not manually annotated as a compound (e.g. "olanzapine chez les enfants" or "olanzapine sur les protéines"). Same mistakes may be observed due to prepositional phrase attachment ambiguity as for example in <ref type="bibr" coords="15,312.19,570.71,17.71,9.96" target="#b11">(12)</ref> Example 12. Traitement de l' ankylostomiase par le tétrachloréthylène chez l' adulte et le grand enfant . [MEDLINE/13515790]</p><p>where our system recognized "ankylostomiase par le tétrachloréthylène" as a DISO because of the pattern NC (B) P DET NC (B) whereas th prepositional phrase "par le tétrachloréthylène" is syntactically attached to "Traitement" and not to "ankylostomiase".</p><p>Moreover, when exact matching, other FPs may be observed such as "troubles hématologiques périphériques" detected as single entity instead of two entities "troubles hématologiques" and "périphériques".</p><p>This compound boundaries problem has very strong consequences on recall and may explain the large amount of FNs (more than 1,300 in EMEA and 2,100 in MEDLINE, see Table <ref type="table" coords="16,275.78,178.10,3.87,9.96" target="#tab_7">4</ref>). Indeed, when "troubles hématologiques périphériques" is detected instead of two entities "troubles hématologiques" and "périphériques", it causes one FP and two FNs. A simple way for dealing with this problem will be to systematically split detected compounds into as many single entities as single words.</p><p>The converse is also observed i.e. when our system extracts only one term from a compound, as for example "Olanzapine Teva" manually annotated as CHEM while our system recognized only "Olanzapine" and not "Teva". Such FNs were essentially due to the limited coverage of our external resources.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0" coords="4,190.92,220.97,233.52,9.21;4,169.35,115.84,276.65,91.12"><head>Fig. 1 .</head><label>1</label><figDesc>Fig. 1. Visualization of annotated entities through BRAT</figDesc><graphic coords="4,169.35,115.84,276.65,91.12" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1" coords="6,247.48,353.99,120.40,9.21;6,152.06,137.28,311.27,202.70"><head>Fig. 2 .</head><label>2</label><figDesc>Fig. 2. System training phase</figDesc><graphic coords="6,152.06,137.28,311.27,202.70" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2" coords="6,240.52,632.83,134.33,9.21;6,152.06,413.49,311.25,205.33"><head>Fig. 3 .</head><label>3</label><figDesc>Fig. 3. Entities annotation phase</figDesc><graphic coords="6,152.06,413.49,311.25,205.33" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3" coords="7,244.60,276.52,77.09,9.96;7,134.77,354.21,411.19,10.18;7,188.29,365.74,362.38,9.41;7,192.99,376.70,221.19,9.41;7,134.77,468.60,411.19,10.18;7,188.29,480.13,362.38,9.41;7,192.99,491.09,155.30,9.41"><head></head><label></label><figDesc>) after correction: Example 5. Par conséquent , lorsque vous serez traité par TYSABRI , vous ne constaterez peut-être pas d ' amélioration mais le traitement par TYSABRI pourra empêcher l ' aggravation de votre maladie . [EMEA/425_6] Example 6. Par conséquent, lorsque vous serez traité par TYSABRI, vous ne constaterez peut-être pas d' amélioration mais le traitement par TYSABRI pourra empêcher l' aggravation de votre maladie.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4" coords="13,134.77,264.26,166.47,10.18;13,188.29,276.79,28.24,9.41;13,244.76,276.79,56.48,9.41;13,188.29,288.74,112.95,9.41"><head>Example 9 .</head><label>9</label><figDesc>hyperplasie (NC) DISO_B focale (ADJ) DISO_I modulaire (ADJ) DISO_I</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5" coords="15,134.77,388.70,71.74,10.18;15,210.34,383.99,43.31,16.47;15,257.48,388.70,229.84,10.18;15,193.38,399.66,15.53,10.18;15,212.47,394.95,41.94,16.47;15,257.98,399.66,107.52,10.18"><head>Example 11 .</head><label>11</label><figDesc>L ' injection sous-cutanée est réalisée de la même façon qu ' avec une seringue classique .[EMEA/334_3]</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" coords="3,134.77,172.34,347.48,231.99"><head></head><label></label><figDesc>Drug inserts are long texts (around 5,000 words/text on average) written in a less specialized language than MEDLINE's very short text segments (6 words/item on average), as illustrated in examples 1 from EMEA and 2 from MEDLINE, see below. MEDLINE texts are written with an uncommon syntax, considering that titles and (sub)headings usually correspond to noun phrases or non-nite sentences without nal punctuation.</figDesc><table coords="3,134.77,172.34,345.83,48.41"><row><cell>1 for the</cell></row><row><cell>general public ;</cell></row><row><cell>MEDLINE: 1665 titles and (sub)headings of biomedical academic papers in-dexed in the MEDLINE database 2 .</cell></row></table><note coords="3,134.77,312.60,347.47,10.18;3,188.29,324.55,293.96,10.18;3,188.29,336.51,293.95,10.18;3,188.29,348.26,283.00,10.46;3,134.77,370.17,347.47,10.18;3,188.29,382.13,293.95,10.18;3,188.29,393.88,125.31,10.46"><p>Example 1. Il est utilisé en association avec d ' autres médicaments antiviraux dans le traitement des adultes et des enfants infectés par le virus de l ' immunodécience humaine ( VIH ), le virus qui provoque le syndrome d ' immunodécience acquise ( SIDA ). [EMEA/118_1] Example 2. Hypersensibilité retardée dans les aections thyroïdiennes étudiée par le test de migration des leucocytes en présence de thyroglobuline humaine . [MEDLINE/4573749]</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2" coords="4,134.77,301.66,347.48,210.50"><head>Table 1 .</head><label>1</label><figDesc>). Amount of annotated data per subset</figDesc><table coords="4,134.77,314.76,347.48,197.40"><row><cell cols="5">Example 4. Prévalence des marqueurs des virus des hépatites A , B , C à La Réunion ( Hôpital sud et prison de Saint Pierre ). [MEDLINE/10774493]</cell></row><row><cell>T2</cell><cell>LIVB 29 34</cell><cell>virus</cell><cell></cell></row><row><cell>T5</cell><cell cols="2">DISO 39 48;57 58 hépatites C</cell><cell></cell></row><row><cell>T7</cell><cell cols="3">LIVB 29 48;57 58 virus des hépatites C</cell></row><row><cell cols="5">Table 1 gives an overview of the amount of annotated data per subset.</cell></row><row><cell>Subset</cell><cell></cell><cell cols="3">EMEA (%) MEDLINE (%) Total (%)</cell></row><row><cell cols="2"># of texts</cell><cell>6</cell><cell>1665</cell><cell>1671</cell></row><row><cell cols="2"># of words</cell><cell>28215</cell><cell>10503</cell><cell>38718</cell></row><row><cell cols="2">Annotated entities</cell><cell>4955</cell><cell>2977</cell><cell>7932</cell></row><row><cell cols="2">Compounds entities</cell><cell>995 20.1</cell><cell cols="2">846 28.5 1841 23.2</cell></row><row><cell cols="2">Discontinuous entities</cell><cell>42 0.8</cell><cell>21 0.7</cell><cell>63 0.8</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4" coords="9,136.16,380.54,414.48,94.79"><head>Table 2 .</head><label>2</label><figDesc>Word lists extracted from SNOMED resource and VIDAL database</figDesc><table coords="9,136.16,412.14,414.48,63.20"><row><cell>Category</cell><cell>Nb of terms Examples</cell></row><row><cell>SNOMED Chimie (chem)</cell><cell>3505 toxine, magnésium, métoxyphénamine</cell></row><row><cell>SNOMED Morphologie (morph)</cell><cell>1033 microfracture, antéexion, hypomyélinisation</cell></row><row><cell>SNOMED Procédure (proc)</cell><cell>62 cystométrogramme, électronystagmographie, thérapie</cell></row><row><cell>SNOMED Agents physiques (phys)</cell><cell>378 garrot, oxymètre, hémocytomètre</cell></row><row><cell>VIDAL drug names (chem)</cell><cell>3873 aspirine, nicopatch, ventoline</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5" coords="11,134.77,313.09,414.15,350.20"><head></head><label></label><figDesc>):</figDesc><table coords="11,134.77,335.49,414.15,327.80"><row><cell>Example 8.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Par_conséquent ADV</cell><cell cols="2">par_conséquent mod</cell><cell>1398 long</cell><cell cols="2">none none none</cell><cell>O</cell></row><row><cell>,</cell><cell cols="2">PONCT ,</cell><cell>ponct</cell><cell cols="3">1413 short none none none</cell><cell>O</cell></row><row><cell>lorsque</cell><cell>CS</cell><cell>lorsque</cell><cell>mod</cell><cell cols="3">1415 medium none none none</cell><cell>O</cell></row><row><cell>vous</cell><cell>CLS</cell><cell>vous</cell><cell>suj</cell><cell cols="3">1423 short none none none</cell><cell>O</cell></row><row><cell>serez</cell><cell>V</cell><cell>être</cell><cell cols="2">aux_pass 1428 short</cell><cell cols="2">none none none</cell><cell>O</cell></row><row><cell>traité</cell><cell>VPP</cell><cell>traiter</cell><cell>sub</cell><cell cols="3">1434 medium none none none</cell><cell>PROC_B</cell></row><row><cell>par</cell><cell>P</cell><cell>par</cell><cell>p_obj</cell><cell cols="3">1441 short none none none</cell><cell>O</cell></row><row><cell>TYSABRI</cell><cell>NPP</cell><cell>TYSABRI</cell><cell>prep</cell><cell cols="3">1445 medium none none chem</cell><cell>CHEM_B</cell></row><row><cell>,</cell><cell cols="2">PONCT ,</cell><cell>ponct</cell><cell cols="3">1453 short none none none</cell><cell>O</cell></row><row><cell>vous</cell><cell>CLS</cell><cell>vous</cell><cell>suj</cell><cell cols="3">1455 short none none none</cell><cell>O</cell></row><row><cell>ne</cell><cell>ADV</cell><cell>ne</cell><cell>mod</cell><cell>1460 short</cell><cell cols="2">none none none</cell><cell>O</cell></row><row><cell>constaterez</cell><cell>V</cell><cell>constater</cell><cell>root</cell><cell>1463 long</cell><cell>con</cell><cell>none none</cell><cell>O</cell></row><row><cell>peut-être</cell><cell>ADV</cell><cell>peut-être</cell><cell>mod</cell><cell cols="3">1475 medium none none none</cell><cell>O</cell></row><row><cell>pas</cell><cell>ADV</cell><cell>pas</cell><cell>mod</cell><cell cols="3">1485 short none none none</cell><cell>O</cell></row><row><cell>d'</cell><cell>DET</cell><cell>de</cell><cell>det</cell><cell>1489 short</cell><cell cols="2">none none none</cell><cell>O</cell></row><row><cell>amélioration</cell><cell>NC</cell><cell>amélioration</cell><cell>obj</cell><cell>1493 long</cell><cell cols="2">none tion none</cell><cell>O</cell></row><row><cell>mais</cell><cell>CC</cell><cell>mais</cell><cell>coord</cell><cell cols="3">1506 short none none none</cell><cell>O</cell></row><row><cell>le</cell><cell>DET</cell><cell>le</cell><cell>det</cell><cell>1511 short</cell><cell cols="2">none none none</cell><cell>O</cell></row><row><cell>traitement</cell><cell>NC</cell><cell>traitement</cell><cell>suj</cell><cell cols="3">1514 medium none ment none</cell><cell>PROC_B</cell></row><row><cell>par</cell><cell>P</cell><cell>par</cell><cell>dep</cell><cell>1525 short</cell><cell cols="2">none none none</cell><cell>O</cell></row><row><cell>TYSABRI</cell><cell>NPP</cell><cell>TYSABRI</cell><cell>prep</cell><cell cols="3">1529 medium none none chem</cell><cell>CHEM_B</cell></row><row><cell>pourra</cell><cell>V</cell><cell>pouvoir</cell><cell cols="4">dep_coord 1537 medium none none none</cell><cell>O</cell></row><row><cell>empêcher</cell><cell cols="2">VINF empêcher</cell><cell>obj</cell><cell cols="3">1544 medium none none none</cell><cell>O</cell></row><row><cell>l'</cell><cell>DET</cell><cell>l'</cell><cell>det</cell><cell>1553 short</cell><cell cols="2">none none none</cell><cell>O</cell></row><row><cell>aggravation</cell><cell>NC</cell><cell>aggravation</cell><cell>obj</cell><cell>1557 long</cell><cell cols="2">none tion none</cell><cell>O</cell></row><row><cell>de</cell><cell>P</cell><cell>de</cell><cell>dep</cell><cell>1569 short</cell><cell cols="2">none none none</cell><cell>O</cell></row><row><cell>votre</cell><cell>DET</cell><cell>votre</cell><cell>det</cell><cell>1572 short</cell><cell cols="2">none none none</cell><cell>O</cell></row><row><cell>maladie</cell><cell>NC</cell><cell>maladie</cell><cell>prep</cell><cell cols="3">1578 medium none none none</cell><cell>DISO_B</cell></row><row><cell>.</cell><cell cols="2">PONCT .</cell><cell>ponct</cell><cell cols="3">1586 short none none none</cell><cell>O</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6" coords="12,166.41,451.86,282.55,83.43"><head>Table 3 .</head><label>3</label><figDesc>Features contribution: F1 variation when feature is removed</figDesc><table coords="12,202.57,472.49,210.22,62.80"><row><cell>F1-score</cell><cell cols="2">EMEA MEDLINE</cell></row><row><cell>All features</cell><cell>0.5429</cell><cell>0.3821</cell></row><row><cell>-Syntactic relations</cell><cell>-0.0003</cell><cell>+0.0046</cell></row><row><cell>-Token length</cell><cell>+0.0109</cell><cell>-0.0038</cell></row><row><cell>-Axes</cell><cell>-0.0085</cell><cell>-0.0227</cell></row><row><cell cols="2">-SNOMED and drugs lexicon -0.0116</cell><cell>-0.0340</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7" coords="14,134.77,222.17,373.06,267.30"><head>Table 4 .</head><label>4</label><figDesc>LITL team scores on test data. For both target data and for each run, number of true positives (TP), fase positives (FP) and false negatives (FN), along with recall, precision and F1 scores, with exact and non-exact matching. Average scores were computed on all submitted runs.</figDesc><table coords="14,134.77,285.04,373.06,204.43"><row><cell>EMEA</cell><cell>exact matching</cell><cell></cell><cell>no exact matching</cell></row><row><cell></cell><cell>TP FP FN Precision Recall</cell><cell cols="2">F1 TP FP FN Precision Recall</cell><cell>F1</cell></row><row><cell>LITL-run1</cell><cell cols="3">879 242 1325 0.7841 0.3988 0.5287 990 131 1069 0.8831 0.4808 0.6226</cell></row><row><cell>LITL-run2</cell><cell cols="3">867 264 1337 0.7666 0.3934 0.5199 995 136 1052 0.8798 0.4861 0.6262</cell></row><row><cell>Average scores</cell><cell cols="2">0.5250 0.4114 0.4350</cell><cell>0.6377 0.5141 0.5423</cell></row><row><cell>MEDLINE</cell><cell>exact matching</cell><cell></cell><cell>no exact matching</cell></row><row><cell></cell><cell>TP FP FN Precision Recall</cell><cell cols="2">F1 TP FP FN Precision Recall</cell><cell>F1</cell></row><row><cell>LITL-run1</cell><cell cols="3">998 556 2105 0.6422 0.3216 0.4286 1247 307 1531 0.8024 0.4489 0.5757</cell></row><row><cell>LITL-run2</cell><cell cols="3">989 561 2114 0.6381 0.3187 0.4251 1237 313 1544 0.7981 0.4448 0.5712</cell></row><row><cell>Average scores</cell><cell cols="2">0.5030 0.4264 0.4455</cell><cell>0.6387 0.5707 0.5859</cell></row><row><cell cols="4">syntactic feature) scores show little dierences as expected, although run 1 gets</cell></row><row><cell cols="4">higher scores for both subsets with exact matching. The order is partly dierent</cell></row><row><cell cols="4">without exact matching where run2 gest slightly higher results for EMEA only.</cell></row><row><cell cols="4">It should be noted that matching option only concerns entity delimitation and</cell></row><row><cell cols="2">not disagreement on entity classication.</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8" coords="15,134.77,115.11,345.83,144.36"><head>Table 5 .</head><label>5</label><figDesc>Quantitative overview of test data set</figDesc><table coords="15,134.77,135.88,345.83,123.59"><row><cell>Subset</cell><cell cols="3">EMEA MEDLINE (%) Total (%)</cell></row><row><cell># of texts</cell><cell>4</cell><cell>833</cell><cell>1671</cell></row><row><cell># of words</cell><cell>12042</cell><cell>10871</cell><cell>22913</cell></row><row><cell>Annotated entities</cell><cell>2070</cell><cell>3150</cell><cell>5220</cell></row><row><cell>Compound entities</cell><cell>499 24.1</cell><cell cols="2">886 28.1 1385 26.5</cell></row><row><cell>Discontinuous entities</cell><cell>42 2.0</cell><cell>23 0.7</cell><cell>65 1.2</cell></row><row><cell cols="4">the proportion of discontinuous entities which were not taken into account by</cell></row><row><cell>our system is double.</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="1" xml:id="foot_0" coords="3,144.73,633.94,160.01,9.41"><p>http://opus.lingfil.uu.se/EMEA.php</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="2" xml:id="foot_1" coords="3,144.73,644.90,164.72,9.41"><p>http://www.ncbi.nlm.nih.gov/pubmed/</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="3" xml:id="foot_2" coords="3,144.73,655.86,169.42,9.41"><p>http://brat.nlplab.org/standoff.html</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="4" xml:id="foot_3" coords="5,144.73,655.86,150.60,9.41"><p>https://taku910.github.io/crfpp/</p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="5" xml:id="foot_4" coords="9,144.73,655.86,89.42,9.41"><p>http://www.vidal.fr</p></note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct coords="16,142.95,328.17,337.64,9.21;16,151.52,339.13,329.07,9.21;16,151.52,350.09,25.59,9.21" xml:id="b0">
	<analytic>
		<title level="a" type="main" coord="16,287.80,328.17,192.80,9.21;16,151.52,339.13,120.87,9.21">Une étude comparative empirique sur la reconnaissance des entités médicales</title>
		<author>
			<persName coords=""><forename type="first">A</forename><forename type="middle">B</forename><surname>Abacha</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">P</forename><surname>Zweigenbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" coord="16,278.90,339.13,150.30,9.21">Traitement Automatique des Langues</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">3968</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="16,142.95,360.95,337.64,9.21;16,151.52,371.90,329.07,9.21;16,151.52,382.86,110.44,9.21" xml:id="b1">
	<monogr>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Ben Abacha</surname></persName>
		</author>
		<title level="m" coord="16,220.40,360.95,260.19,9.21;16,151.52,371.90,139.67,9.21">Recherche de réponses précises à des questions médicales : le système de questions-réponses MEANS</title>
		<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">XI</biblScope>
		</imprint>
		<respStmt>
			<orgName>Université Paris Sud -Paris</orgName>
		</respStmt>
	</monogr>
	<note type="report_type">Thèse de doctorat en informatique</note>
</biblStruct>

<biblStruct coords="16,142.95,393.72,337.64,9.21;16,151.52,404.68,329.07,9.21;16,151.52,415.64,329.08,9.21;16,151.52,426.60,25.59,9.21" xml:id="b2">
	<analytic>
		<title level="a" type="main" coord="16,414.53,393.72,66.06,9.21;16,151.52,404.68,329.07,9.21;16,151.52,415.64,35.97,9.21">Machine-learned solutions for three stages of clinical information extraction: the state of the art at i2b2 2010</title>
		<author>
			<persName coords=""><forename type="first">B</forename><surname>De Bruijn</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">C</forename><surname>Cherry</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Kiritchenko</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">J</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">X</forename><surname>Zhu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" coord="16,193.98,415.64,226.25,9.21">Journal of the American Medical Informatics Association</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">557562</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="16,142.95,437.45,337.64,9.21;16,151.52,448.41,301.94,9.21" xml:id="b3">
	<monogr>
		<title level="m" type="main" coord="16,217.22,437.45,263.38,9.21;16,151.52,448.41,59.73,9.21">Disease Name Extraction from Clinical Text Using Conditional Random Fields</title>
		<author>
			<persName coords=""><forename type="first">O</forename><surname>Ghiasvand</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
		<respStmt>
			<orgName>University of Wisconsin-Milwaukee</orgName>
		</respStmt>
	</monogr>
	<note type="report_type">Master&apos;s thesis</note>
</biblStruct>

<biblStruct coords="16,142.95,459.27,337.63,9.21;16,151.52,470.23,329.07,9.21;16,151.52,481.18,329.08,9.21;16,151.52,492.14,145.31,9.21" xml:id="b4">
	<analytic>
		<title level="a" type="main" coord="16,442.94,459.27,37.64,9.21;16,151.52,470.23,132.96,9.21">Overview of the clef ehealth evaluation lab</title>
		<author>
			<persName coords=""><forename type="first">L</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">L</forename><surname>Goeuriot</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">H</forename><surname>Suominen</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Névéol</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">J</forename><surname>Palotti</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">G</forename><surname>Zuccon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="16,326.36,470.23,154.23,9.21;16,151.52,481.18,173.65,9.21">Proceedings of CLEF 2016 -7th Conference and Labs of the Evaluation Forum</title>
		<title level="s" coord="16,333.99,481.18,146.60,9.21;16,151.52,492.14,24.40,9.21">Lecture Notes in Computer Science (LNCS</title>
		<meeting>CLEF 2016 -7th Conference and Labs of the Evaluation Forum</meeting>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2016-09">2016. September 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="16,142.95,503.00,337.64,9.21;16,151.52,513.96,329.07,9.21;16,151.52,524.92,304.63,9.21" xml:id="b5">
	<analytic>
		<title level="a" type="main" coord="16,315.65,503.00,164.94,9.21;16,151.52,513.96,206.81,9.21">Conditional Random Fields: Probabilistic models for segmenting and labeling sequence data</title>
		<author>
			<persName coords=""><forename type="first">J</forename><surname>Laerty</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Mccallum</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">F</forename><forename type="middle">C</forename><surname>Pereira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="16,381.81,513.96,98.77,9.21;16,151.52,524.92,219.93,9.21">Proceedings of the 18th International Conference on Machine Learning (ICML)</title>
		<meeting>the 18th International Conference on Machine Learning (ICML)</meeting>
		<imprint>
			<date type="published" when="2001">2001</date>
			<biblScope unit="page">282289</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="16,142.95,535.77,337.64,9.21;16,151.52,546.73,329.08,9.21;16,151.52,557.69,109.02,9.21" xml:id="b6">
	<analytic>
		<title level="a" type="main" coord="16,294.74,535.77,185.85,9.21;16,151.52,546.73,149.68,9.21">Banner: an executable survey of advances in biomedical named entity recognition</title>
		<author>
			<persName coords=""><forename type="first">R</forename><surname>Leaman</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">G</forename><surname>Gonzalez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="16,325.18,546.73,150.88,9.21">Pacic Symposium on Biocomputing</title>
		<imprint>
			<date type="published" when="2008">2008</date>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">652663</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="16,142.95,568.55,337.64,9.21;16,151.52,579.51,329.08,9.21;16,151.52,590.46,253.69,9.21" xml:id="b7">
	<monogr>
		<title level="m" type="main" coord="16,342.68,568.55,137.91,9.21;16,151.52,579.51,329.08,9.21;16,151.52,590.46,203.52,9.21">Feature engineering for drug name recognition in biomedical texts: Feature conjunction and feature selection. Computational and mathematical methods in medicine</title>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">B</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">Q</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">X</forename><surname>Fan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="16,142.95,601.32,337.63,9.21;16,151.52,612.28,187.37,9.21" xml:id="b8">
	<analytic>
		<title level="a" type="main" coord="16,250.75,601.32,225.74,9.21">A survey of named entity recognition and classication</title>
		<author>
			<persName coords=""><forename type="first">D</forename><surname>Nadeau</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Sekine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" coord="16,151.52,612.28,110.59,9.21">Lingvisticae Investigationes</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">326</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="16,142.61,623.14,337.97,9.21;16,151.52,634.09,329.08,9.21;16,151.52,645.05,329.08,9.21;16,151.52,656.01,299.78,9.21" xml:id="b9">
	<analytic>
		<title level="a" type="main" coord="16,357.36,634.09,123.24,9.21;16,151.52,645.05,133.01,9.21">Clinical information extraction at the clef ehealth evaluation lab</title>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Névéol</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">L</forename><surname>Goeuriot</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">L</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">K</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">C</forename><surname>Grouin</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">T</forename><surname>Hamon</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">T</forename><surname>Lavergne</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">G</forename><surname>Rey</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Robert</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">X</forename><surname>Tannier</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">P</forename><surname>Zweigenbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="16,325.98,645.05,154.61,9.21;16,151.52,656.01,173.96,9.21">Proceedings of CLEF 2016 Evaluation Labs and Workshop: Online Working Notes</title>
		<meeting>CLEF 2016 Evaluation Labs and Workshop: Online Working Notes</meeting>
		<imprint>
			<publisher>CEUR-WS</publisher>
			<date type="published" when="2016-09">2016. September 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="17,142.61,118.89,337.98,9.21;17,151.52,129.85,235.49,9.21;17,408.44,129.85,72.15,9.21;17,151.52,140.81,136.81,9.21" xml:id="b10">
	<analytic>
		<title level="a" type="main" coord="17,402.64,118.89,77.96,9.21;17,151.52,129.85,235.49,9.21;17,408.44,129.85,53.73,9.21">The Quaero French medical corpus: A ressource for medical entity recognition normalization</title>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Névéol</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">C</forename><surname>Grouin</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">J</forename><surname>Leixa</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Rosset</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">P</forename><surname>Zweigenbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="17,151.52,140.81,60.24,9.21">Proc BioTextM</title>
		<meeting>BioTextM<address><addrLine>Reykjavik</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="17,142.61,151.76,337.98,9.21;17,151.52,162.72,329.07,9.21;17,151.52,173.68,150.55,9.21" xml:id="b11">
	<analytic>
		<title level="a" type="main" coord="17,193.45,162.72,287.14,9.21;17,151.52,173.68,14.74,9.21">Clef ehealth evaluation lab 2015 task 1b: clinical named entity recognition</title>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Névéol</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">C</forename><surname>Grouin</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">X</forename><surname>Tannier</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">T</forename><surname>Hamon</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">L</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">L</forename><surname>Goeuriot</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">P</forename><surname>Zweigenbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="17,187.09,173.68,86.33,9.21">Proceedings of CLEF</title>
		<meeting>CLEF</meeting>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="17,142.61,184.64,337.98,9.21;17,151.52,195.60,329.07,9.21;17,151.52,206.56,329.07,9.21;17,151.52,217.52,195.92,9.21" xml:id="b12">
	<analytic>
		<title level="a" type="main" coord="17,245.85,184.64,234.74,9.21;17,151.52,195.60,251.21,9.21">L&apos;apport du faisceau dans l&apos;analyse syntaxique en dépendances par transitions : études de cas avec l&apos;analyseur Talismane</title>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Urieli</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">L</forename><surname>Tanguy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="17,422.37,195.60,58.22,9.21;17,151.52,206.56,324.39,9.21">Actes de la 20e conférence sur le Traitement Automatique des Langues Naturelles (TALN&apos;2013)</title>
		<meeting>s de la 20e conférence sur le Traitement Automatique des Langues Naturelles (TALN&apos;2013)<address><addrLine>Les Sables d&apos;Olonne, France</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="page">188201</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="17,142.61,228.48,337.98,9.21;17,151.52,239.44,329.07,9.21;17,151.52,250.39,282.27,9.21" xml:id="b13">
	<analytic>
		<title level="a" type="main" coord="17,326.75,228.48,153.84,9.21;17,151.52,239.44,200.16,9.21">The SNOMED clinical terms development process: renement and analysis of content</title>
		<author>
			<persName coords=""><forename type="first">A</forename><forename type="middle">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">J</forename><forename type="middle">H</forename><surname>Sable</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">K</forename><forename type="middle">A</forename><surname>Spackman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="17,374.72,239.44,105.87,9.21;17,151.52,250.39,44.27,9.21">Proceedings of the AMIA Symposium</title>
		<meeting>the AMIA Symposium</meeting>
		<imprint>
			<publisher>American Medical Informatics Association</publisher>
			<date type="published" when="2002">2002</date>
			<biblScope unit="page">845</biblScope>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
